Getinge (OTCMKTS:GNGBY) Releases Quarterly Earnings Results

Getinge (OTCMKTS:GNGBY) released its quarterly earnings data on Friday. The company reported $0.38 earnings per share for the quarter, Zacks reports. Getinge had a return on equity of 10.39% and a net margin of 6.92%.

Getinge Trading Up 0.8%

OTCMKTS:GNGBY opened at $21.70 on Friday. The company has a market cap of $5.91 billion, a P/E ratio of 23.59 and a beta of 0.96. Getinge has a twelve month low of $18.99 and a twelve month high of $24.67. The business has a 50 day moving average price of $20.57 and a two-hundred day moving average price of $21.32. The company has a quick ratio of 0.86, a current ratio of 1.32 and a debt-to-equity ratio of 0.27.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of Getinge to a “hold” rating in a report on Thursday, April 23rd. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy”.

About Getinge

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.